🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

Within minutes of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display black plastic packages with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious medical dangers”.